Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q4 2020 Nordic Nanovector ASA Earnings Call Transcript

Feb 18, 2021 / 07:30AM GMT
Release Date Price: kr19.59 (+46.84%)
Jan Hendrik Egberts
Nordic Nanovector ASA - Independent Chairman of the Board

Good morning, ladies and gentlemen. Welcome to our Q4 and full year 2020 highlights and financials. My name is Jan Egberts, and I'm Chairman of the Board. And I'm here together with Lars Nieba, our interim CEO; Malene Brondberg, our CFO; and Marco Renoldi, our COO.

Over the past year, I've acted someone as an Executive Chairman, spent quite a bit of time with the company. Most of my colleague Board members have worked very intensely over the past year.

First of all, I want to acknowledge this had been a very difficult year and a somewhat disappointing year for all of you and all our shareholders since our stock price has not performed at all over the past year. Unfortunately, we had to spend that year focusing on a number of very important operational fixes, which, unfortunately, resulted that we had very little news to report. But I'm very pleased that I think today, we can report some very positive news to you, and I know you have been waiting for a long time with that.

In the next presentation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot